Evotec is participating in the €8 million ($8.46 million) Series A of its current partner in developing metabolic disease therapy Eternygen.

Draper has signed a three-year deal with Big Pharma giant Pfizer to help predict clinical outcomes from an early stage through the use of its…

Aptuit, a CRO focused on early to mid-phase drug development, has inked a deal with Chiesi Farmaceutici to develop new drugs for idiopathic pulmonary fibrosis.

Crown Bioscience will invest $1 million into establishment of a pharmaceutical R&D facility in Louisiana at New Iberia Research Center, one of the country’…

The European Medicines Agency has started a review of medicines whose studies have been conducted at either of the two sites of Micro Therapeutic Research Labs…

The European Medicines Agency recently held a workshop with stakeholders about adaptive pathways, which also allows more real-world data into drug approvals.

Martine Dehlinger-Kremer, VP of global medical and regulatory affairs at SynteractHCR, was elected president of the European CRO Federation, which represents…

INC Research is planning to move its headquarters to a nearby site in North Carolina, invest $38 million for 550 new jobs over the next five years.

The 21st Century Cures Act has already passed both section of the Congress, but several proposed changes to the clinical research and drug approval process…

CRO